TMS vs. Ketamine Therapy: What’s the Difference?
April 7, 2026
When depression doesn’t improve with traditional medications or therapy, it can feel discouraging. Many people begin looking into advanced treatment options and quickly come across two names: TMS and ketamine therapy.
They’re often mentioned in the same breath.
But they’re not the same experience — and they don’t work in the same way.
Understanding the differences can help you feel more grounded as you consider what might be right for you.
Both TMS (Transcranial Magnetic Stimulation) and ketamine therapy are used for treatment-resistant depression. Both are offered in structured medical settings. Both aim to help when standard antidepressants haven’t provided enough relief.
But they take different routes.
TMS uses targeted magnetic pulses to stimulate specific areas of the brain involved in mood regulation. It’s non-invasive and doesn’t involve medication entering the bloodstream.
Ketamine therapy works through the brain’s glutamate system. Rather than stimulating one region repeatedly, it temporarily shifts neural communication more broadly, which may support increased neuroplasticity — the brain’s ability to form new neural connections involved in mood and emotional processing.
Different tools. Different mechanisms. Same intention: helping the brain move out of stuck patterns.
TMS sessions are typically brief and done five days a week for several weeks. You sit in a chair while a device delivers rhythmic tapping sensations to the scalp.
Some people describe it as mildly uncomfortable at first, though many adjust quickly. There’s no sedation, and you can drive yourself home afterward.
Improvement tends to build gradually. It’s not usually immediate. Think of it as steady repetition over time. Many individuals complete 20–36 sessions over four to six weeks before evaluating overall progress.
Ketamine infusions are different.
The experience is often described as creating mental “space.” During treatment, perception may shift temporarily. Thoughts may feel quieter. Some people experience imagery or emotional release. Others feel calm and detached.
There’s no single correct experience.
Sessions are monitored closely, and you remain in the clinic until the effects settle. Many individuals report noticing changes in mood sooner than with traditional medications, and sometimes earlier than other advanced interventions, though response varies from person to person.
Ketamine protocols typically involve a series of treatments over several weeks, followed by maintenance sessions when appropriate. Compared to approaches that require near-daily clinic visits, some patients appreciate the reduced scheduling burden.
The treatment itself is only part of the process. What you do afterward — therapy, reflection, daily routines — often matters just as much.
One of the most common questions is about speed. TMS usually requires multiple weeks before noticeable improvement develops.
Ketamine can sometimes produce shifts more quickly for certain individuals, particularly because it works through a different brain pathway than traditional antidepressants.
But faster doesn’t automatically mean better.
Both approaches require follow-up. Both benefit from integration with therapy. Neither guarantees relief. Depression recovery rarely moves in a straight line.
Both treatments are considered safe when delivered in appropriate clinical settings.
TMS is non-systemic, meaning it doesn’t circulate through the body. Side effects are typically limited to mild scalp discomfort or headache.
Ketamine temporarily alters perception and can raise blood pressure during administration, which is why medical monitoring is required. In controlled clinical environments, this monitoring helps ensure the treatment is delivered safely and responsibly.
Before either treatment begins, providers assess medical history, psychiatric stability, and overall risk profile. Not everyone is a candidate for every option.
There isn’t a universal answer.
Some people prefer a non-medication approach like TMS. Others are drawn to the rapid-acting potential of ketamine therapy or the different biological pathway it targets. Some try one before the other. Some combine advanced treatments with ongoing medication management.
The right decision depends on:
A structured consultation can help clarify what makes sense for you.
Online comparisons sometimes frame this as a competition.
That’s rarely helpful.
Both TMS and ketamine therapy are tools. The goal isn’t to choose the “most powerful” option — it’s to choose the one that aligns with your nervous system, your history, and your long-term plan.
The treatment is only part of the work. Sustainable improvement usually involves therapy, consistency, and support.
Exploring advanced depression treatments can feel overwhelming. There’s a lot of information — and a lot of opinions.
At New Pathways Clinic, we approach these decisions thoughtfully. We focus on safety, structure, and realistic expectations rather than quick promises.
If you’re considering TMS or ketamine therapy, a consultation can help you sort through the differences and determine what fits your needs.
There’s no pressure. Just information and support.
Effectiveness varies from person to person. Some individuals respond well to TMS, while others experience meaningful changes with ketamine therapy.
Some research suggests ketamine may produce higher response rates in certain treatment-resistant populations, though outcomes depend on diagnosis, treatment history, and individual neurobiology.
TMS typically produces gradual improvement over several weeks of consistent sessions. Ketamine therapy may create shifts sooner for some individuals because it works through a different neurological pathway than traditional antidepressants.
However, response timelines vary, and early improvements still require continued support and monitoring.
In some cases, individuals explore both options at different points in their care. Treatment sequencing depends on clinical history and provider guidance. Decisions are made carefully rather than impulsively.
Insurance coverage varies by plan and diagnosis. TMS and Spravato often have clearer insurance pathways, while IV ketamine coverage can differ. Clinics typically verify benefits before beginning treatment, so there are no surprises.
